Diabetes Staging System: Understanding Type 1, Type 2, and Prediabetes

”

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or qualified health provider with any questions you may have regarding a medical condition.

Diabetes isn't one condition—it's a group of metabolic disorders with different causes, treatments, and prognoses. Understanding the type of diabetes you have (or are at risk for) is crucial because treatment approaches vary dramatically.

The 2025 ADA guidelines emphasize a staging system that views diabetes as a continuum rather than a binary "you have it or you don't" condition.

Rather than viewing diabetes as an all-or-nothing diagnosis, the 2025 standards encourage clinicians to think in stages:

Stage 1: No Diabetes

• A1C: Below 5.7%
• Status: Normal glucose metabolism
• Action: Maintain healthy lifestyle habits

Stage 2: Prediabetes (At Risk)

• A1C: 5.7% - 6.4%
• Fasting glucose: 100 - 125 mg/dL
• Status: Insulin resistance, elevated cardiovascular risk
• Action: Intensive lifestyle intervention, consider metformin

Stage 3: Early Diabetes

• A1C: 6.5% - 8.5%
• Status: Recent onset, may be reversible with significant intervention
• Action: Lifestyle + medication, focus on remission if appropriate

Stage 4: Established Diabetes

• A1C: Above 8.5% at diagnosis or long-standing
• Status: Significant beta cell dysfunction
• Action: Comprehensive therapy, complication screening

Why staging matters: Earlier stages offer opportunities for intervention and potential remission. The old binary system didn't capture this nuance.

What Is Type 1 Diabetes?

Type 1 diabetes is an autoimmune condition in which the body's immune system destroys the insulin-producing beta cells in the pancreas. Without insulin, glucose cannot enter cells, leading to high blood sugar.

Key Characteristics

Symptoms of Type 1 Diabetes

Onset is often rapid and dramatic:

• Extreme thirst (polydipsia)
• Frequent urination (polyuria)
• Unintentional weight loss
• Extreme hunger (polyphagia)
• Fatigue and weakness
• Blurred vision
• Fruity breath odor (from ketones)
• Diabetic ketoacidosis (DKA) at diagnosis in ~30% of cases

Diagnosis

Type 1 diabetes is diagnosed based on:

• Hyperglycemia (random glucose ≥ 200 mg/dL with symptoms OR fasting glucose ≥ 126 mg/dL OR A1C ≥ 6.5%)
• PLUS one or more diabetes autoantibodies
• PLUS low or undetectable C-peptide (indicating no insulin production)

Treatment

• Insulin is mandatory—delivered via injections or pump
• Carbohydrate counting to dose mealtime insulin
• Frequent blood glucose monitoring (CGM standard of care)
• DKA prevention through sick-day rules and ketone monitoring

What Is Type 2 Diabetes?

Type 2 diabetes is characterized by insulin resistance (cells don't respond properly to insulin) combined with relative insulin deficiency (the pancreas can't make enough to overcome resistance).

Key Characteristics

Symptoms of Type 2 Diabetes

Onset is gradual; symptoms may be mild or absent:

• Increased thirst and urination
• Fatigue
• Blurred vision
• Slow wound healing
• Frequent infections
• Numbness or tingling in hands/feet (neuropathy)
• Darkened skin patches (acanthosis nigricans)

Often discovered incidentally on lab work.

Diagnosis

Same criteria as type 1:

• A1C ≥ 6.5%, OR
• Fasting glucose ≥ 126 mg/dL, OR
• 2-hour OGTT ≥ 200 mg/dL, OR
• Random glucose ≥ 200 mg/dL with symptoms

Differentiated from type 1 by:

• Absence of autoantibodies
• Presence of insulin resistance features (obesity, acanthosis nigricans)
• Measurable C-peptide
• No history of DKA (unless under extreme stress)

Treatment

Lifestyle changes plus one or more of:

• Metformin (first-line for most)
• GLP-1 receptor agonists
• SGLT2 inhibitors
• DPP-4 inhibitors
• Sulfonylureas
• Insulin (when needed)

What Is LADA?

LADA (also called type 1.5 diabetes) is a slowly progressing form of autoimmune diabetes that initially presents like type 2 but is actually type 1.

Key Features

• Onset: Adulthood (usually >30 years)
• Initial presentation: May not require insulin initially
• Autoantibodies: Present (usually GAD65)
• Progression: Beta cell destruction occurs over months to years
• Insulin requirement: Eventually required (often within 5 years)

Why LADA Matters

LADA is often misdiagnosed as type 2 diabetes because:

• Patients are often adults
• They may not be significantly overweight
• They may initially respond to oral medications

Correct diagnosis is important because:

• Oral medications will eventually fail
• Early insulin preserves remaining beta cell function
• Patient education differs (insulin dependence is inevitable)

When to Suspect LADA

Consider LADA if:

• Diagnosed with "type 2" but lean or normal weight
• No strong family history of type 2 diabetes
• Poor response to oral medications
• Low or normal C-peptide despite hyperglycemia
• Presence of autoantibodies (especially GAD65)

What Is Gestational Diabetes Mellitus (GDM)?

GDM is diabetes diagnosed during pregnancy (usually 24-28 weeks gestation) in women who did not have diabetes before pregnancy. It occurs when pregnancy hormones cause insulin resistance.

Risk Factors

• Age > 25 years
• BMI ≥ 25 kg/m²
• Family history of diabetes
• Previous GDM or macrosomic baby
• Certain ethnicities (Hispanic, Black, Native American, Asian)
• PCOS

Screening and Diagnosis

Universal screening at 24-28 weeks with a 1-step or 2-step approach:

1-step (IADPSG criteria): 75g OGTT with fasting, 1-hour, and 2-hour measurements

• Diagnosis if any value meets/exceeds:
  • Fasting: 92 mg/dL
  • 1-hour: 180 mg/dL
  • 2-hour: 153 mg/dL

2-step (traditional US approach):

1. Screen with 50g glucose load (1-hour only)
2. If positive (≥ 140 mg/dL), proceed to diagnostic 100g OGTT
3. Diagnosis if ≥ 2 of 4 values are abnormal using Carpenter-Coustan criteria

Treatment

• Medical nutrition therapy
• Blood glucose monitoring (fasting and postprandial)
• Insulin if targets not met (glyburide or metformin are alternatives but insulin preferred)
• Tight glucose targets to prevent complications

What Is MODY?

MODY is a monogenic form of diabetes caused by mutations in a single gene. It's often misdiagnosed as type 1 or type 2.

Key Features

• Onset: Usually before age 25
• Autosomal dominant inheritance: 50% chance of passing to children
• No autoantibodies
• No significant insulin resistance
• Variable insulin requirement: Depends on the specific gene mutation

Common MODY Types

When to Suspect MODY

Consider genetic testing for MODY if:

• Diabetes diagnosed before age 25
• Parent with diabetes diagnosed before age 50
• No features of type 1 (no autoantibodies)
• No features of type 2 (no insulin resistance, not overweight)
• Stable, mild hyperglycemia over years (especially MODY 2)

Diabetes can also result from other medical conditions or medications:

Causes of Secondary Diabetes

• Pancreatic disease: Pancreatitis, pancreatic cancer, cystic fibrosis
• Endocrine disorders: Cushing syndrome, acromegaly, pheochromocytoma
• Medications: Glucocorticoids, antipsychotics, certain HIV medications
• Genetic syndromes: Down syndrome, Turner syndrome, Klinefelter syndrome

Treatment Implications

Misdiagnosis Consequences

• Type 1 misdiagnosed as type 2: DKA risk, delayed insulin
• Type 2 misdiagnosed as type 1: Unnecessary insulin, burden
• MODY misdiagnosed: Inappropriate treatment (insulin for MODY 3 when sulfonylurea would work)

If you're unsure about your diabetes diagnosis, ask your doctor:

1. What autoantibodies were checked?
2. What is my C-peptide level?
3. Is insulin absolutely required now?
4. Could I have LADA or MODY?

Join WellAlly today to track your diagnosis, lab results, and treatment journey all in one place.

Sources:

• American Diabetes Association. Standards of Care in Diabetes—2025. Diabetes Care 2025; 48(Suppl 1)
• ADA Diabetes Types
• Beyond Type 1

• Prediabetes Diagnosis: When Your Blood Sugar Is High but Not Diabetes Yet
• Diabetes Diagnosis Criteria 2025: A1C, Fasting Glucose, and OGTT Explained